Afterwards, in a post-hoc test, we observed a significant increase of BMP-2 positive cancer cells in both the G_2 (325.9 ± 16.71) and G_3 (332.6 ± 23.69) groups when compared to the G_1 group (93.42 ± 16.95) (G_1 v.s. G_3, p < 0.0001; G_2 v.s. G_1, p < 0.0001) (Figure 3B). The gene discussed is BMP2; the disease is cancer.